|
1
|
AshaRani PV, Low Kah Mun G, Hande MP and
Valiyaveettil S: Cytotoxicity and genotoxicity of silver
nanoparticles in human cells. ACS Nano. 3:279–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu X, Yang Q, Bai J, Lu T, Li Y and Jing
X: Fabrication of biodegradable electrospun
poly(L-lactide-co-glycolide) fibers with antimicrobial nanosilver
particles. J Nanosci Nanotechno. 8:5066–5070. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk
JM, Lau GK and Che CM: Silver nanoparticles inhibit hepatitis B
virus replication. Antivir Ther. 13:253–262. 2008.PubMed/NCBI
|
|
4
|
Schroeder S, Heller DA, Winslow MM, et al:
Treating metastatic cancer with nanotechnology. Nat Rev Cancer.
12:39–50. 2011. View
Article : Google Scholar
|
|
5
|
Weiskirchen R and Gressner AM: Isolation
and culture of hepatic stellate cells. Methods Mol Med. 117:99–113.
2005.PubMed/NCBI
|
|
6
|
Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L
and Rodriguez-Padilla C: Mode of antiviral action of silver
nanoparticles against HIV-1. J Nanobiotechnology. 8:1–10. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gopinath P, Gogoi SK, Chattopadhyay A and
Ghosh SS: Implications of silver nanoparticle induced cell
apoptosis for in vitro gene therapy. Nanotechnology. 19:104–113.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan Y, Liu C, Qian J, Wang J and Zhang Y:
Size-mediated cytotoxicity and apoptosis of hydroxyapatite
nanoparticles in human hepatoma HepG2 cells. Biomaterials.
31:730–740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abdelhalim MA and Jarrar BM: Gold
nanoparticles induced cloudy swelling to hydropic degeneration,
cytoplasmic hyaline vacuolation, polymorphism, binucleation,
karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver.
Lipids Health Dis. 10:1662011. View Article : Google Scholar
|
|
10
|
Li Y, Tian X, Lu Z, Yang C, Yang G, Zhou
X, Yao H, Zhu Z, Xi Z and Yang X: Mechanism for
alpha-MnO2 nanowire-induced cytotoxicity in Hela cells.
J Nanosci Nanotechnol. 10:397–404. 2010.PubMed/NCBI
|
|
11
|
Zamzami N and Kroemer G: Condensed matter
in cell death. Nature. 401:127–128. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Urne AG and Vaux DL: Molecular and
clinical aspects of apoptosis. Pharmacol Ther. 72:37–50. 1996.
View Article : Google Scholar
|
|
13
|
Schrand AM, Rahman MF, Hussain SM,
Schlager JJ, Smith DA and Syed AF: Metal-based nanoparticles and
their toxicity assessment. Wiley Interdiscip Rev Nanomed
Nanobiotechnol. 2:544–568. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zamzami N, Marchetti P, Castedo M, Zanin
C, Vayssière JL, Petit PX and Kroemer G: Reduction in mitochondrial
potential constitutes an early irreversible step of programmed
lymphocyte death in vivo. J Exp Med. 181:1661–1672. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Piao MJ, Kang KA, Lee IK, Kim HS, Kim S,
Choi JY, Choi J and Hyun JW: Silver nanoparticles induce oxidative
cell damage in human liver cells through inhibition of reduced
glutathione and induction of mitochondria-involved apoptosis.
Toxicol Lett. 201:92–100. 2011. View Article : Google Scholar
|
|
17
|
Kroemer G, Zamzami N and Susin SA:
Mitochondrial control of apoptosis. Immunol Today. 18:44–51. 1997.
View Article : Google Scholar
|
|
18
|
Chung TW, Kim JR, Suh JI, Lee YC, Chang
YC, Chung TH and Kim CH: Correlation between plasma levels of
matrix metalloproteinase (MMP)-9/MMP-2 ratio and alpha-fetoproteins
in chronic hepatitis carrying hepatitis B virus. J Gastroen
Hepatol. 19:565–571. 2004. View Article : Google Scholar
|
|
19
|
Lichtinghagen R, Huegel O, Seifert T, et
al: Expression of matrix metalloproteinase-2 and −9 and their
inhibitors in peripheral blood cells of patients with chronic
hepatitis C. Clin Chem. 46:183–192. 2000.
|
|
20
|
Chen JS, Wang Q, Fu XH, Huang XH, Chen XL,
Cao LQ, Chen LZ, Tan HX, Li W, Bi J and Zhang LJ: Involvement of
PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: Association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
